Corcept Therapeutics Incorporated Board of Directors

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Dr. Joseph K. Belanoff M.D.

Dr. Joseph K. Belanoff M.D.

Co-Founder, President, CEO & Director

Mr. Gary Charles Robb J.D.

Mr. Gary Charles Robb J.D.

Chief Business Officer & Secretary

Ms. Monica Tellado

Ms. Monica Tellado

President of Emerging Markets

Ms. Amy Flood

Ms. Amy Flood

Chief Human Resources & Communications Officer

Dr. William Guyer Pharm.D.

Dr. William Guyer Pharm.D.

Chief Development Officer

Mr. Joseph Douglas Lyon

Mr. Joseph Douglas Lyon

Chief Accounting & Technology Officer

Mr. Roberto W. Vieira

Mr. Roberto W. Vieira

President of Oncology

Mr. Sean Maduck

Mr. Sean Maduck

President of Endocrinology

Dr. Hazel Hunt Ph.D.

Dr. Hazel Hunt Ph.D.

Chief Scientific Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.